Bain Capital Specialty Finance, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bain Capital Specialty Finance, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.78M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $18.70M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $23.72M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $28.55M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $22.14M | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | $33.10M | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | $29.09M | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | $35.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $31.06M | Feb 27, 2026 |
| FY2025 | Sep 30, 2023 | $33.86M | Feb 27, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.52M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($27.10M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $219.26M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($316.83M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $265.55M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $89.42M | Feb 28, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.66B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.63B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.47B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.59B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $2.57B | Feb 28, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.55B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.49B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.34B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.48B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.47B | Feb 28, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.12B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.14B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.14B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.12B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.10B | Feb 28, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($43.77M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($19.89M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($31.98M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($52.06M) | Feb 27, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.09M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $51.56M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $43.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $30.21M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $87.44M | Feb 28, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.47B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.39B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.26B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.39B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.41B | Feb 28, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2023 | 0 | Feb 27, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2023 | 0 | Feb 27, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 64.87M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 64.56M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 64.56M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 64.56M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 64.56M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 64.56M | Feb 28, 2023 |